Clik here to view.
Jim Cramer: Buy Best Buy, Bristol-Myers Squibb, and These 2 Stocks
Jim Cramer made the following calls on October 29th, 2013. What do you think about his picks? Best Buy Co. Inc. (NYSE:BBY): Jim Cramer ranked this stock a Buy. Cramer previously ranked this stock a Buy...
View ArticleClik here to view.
Analysts: GE Can Meet or Beat 2013 Expectations and 3 More Research Notes to...
General Electric Co. (NYSE:GE): UBS believes that General Electric’s risk/reward profile is favorable through the end of the year and is on track to meet or even beat its fiscal year 2013 expectations....
View ArticleClik here to view.
4 Healthcare Stock Stories for Midweek Investment Wellness
GlaxoSmithKline Plc (NYSE:GSK): Closing price $53.32 Drug makers GlaxoSmithKline and Lupin Ltd. are among others who must deal with Indian distributors, whose insistence upon maintaining commissions...
View ArticleClik here to view.
4 Mergers and Acquisitions Stock Stories for a Savvy Friday Read
Alcatel-Lucent SA (NYSE:ALU): Current price $4.07 Sources told Reuters that Alcatel-Lucent is exploring the sale ohttps://www.cheatsheet.com/wp-admin/post.php?post=562117&action=editf a unit that...
View ArticleClik here to view.
Merck’s New Cancer Drug Boosts Its Rating
Merck & Co., Inc.’s (NYSE:MRK) shares are at a 52-week high on Monday after a recent upgrade to the company’s shares, even as the majority of the market is sluggish at the start of the new year,...
View ArticleClik here to view.
Bristol-Myers and Pfizer Win Approval of New Indication for Eliquis
Bristol-Myers Squibb & Co. (NYSE:BMY) and Pfizer Inc. (NYSE:PFE) announced today that the FDA has approved an additional indication of Bristol’s anti-blood clot medicine, Eliquis. The drug is now...
View ArticleClik here to view.
Can Merck, Bristol-Myers, or AbbVie Compete with Gilead’s Cure for Hepatitis C?
Source: Thinkstock The race for a hepatitis C cure is closing in fast; Bristol-Myers Squibb Co. (NYSE:BMY) and Merck & Co. Inc. (NYSE:MRK) both announced Thursday that clinical trials of their...
View ArticleClik here to view.
6 Drugs That Could Move the Pharma Market
Overview In the last few years, a number of promising drugs that treat serious conditions and diseases have come through drugmakers’ pipelines. Recent developments in oncology, for instance, mean that...
View ArticleClik here to view.
The Top 5 Biggest Pharma Deals of 2013
5. AstraZeneca/Bristol-Myers Squibb Co. AstraZeneca Group Plc (NYSE:AZN) and Bristol-Myers Squibb Co. (NYSE:BMY) had been in a long-term partnership for six years before Bristol-Myers Squibb decided...
View ArticleClik here to view.
Which of These 10 Best Selling Cancer Drugs Are Here to Stay?
Source: Thinkstock If you look at the pharmaceutical industry’s most promising investigational drugs (which you can do right here), cancer therapies comprise the vast majority of the industry’s recent...
View Article